The ATRA-dependent overexpression of the glutamate transporter EAAC1 requires RARβ induction

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 9, 2009, Pages 1861-1868

  Bianchi, Massimiliano G ^a   Gazzola, Gian C ^a   Cagnin, Silvia ^a   Kagechika, Hiroyuki ^b   Bussolati, Ovidio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

C6 cells; EAAT3; Glioma; Retinoids; RXR; Slc1a1; Transport

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMATE TRANSPORTER; MESSENGER RNA; PROTEIN EAAC1; PROTEIN RFX1; RECEPTOR BLOCKING AGENT; RETINOIC ACID; RETINOIC ACID RECEPTOR BETA; TAMIBAROTENE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; GENE SILENCING; GLIOMA CELL; HALF LIFE TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; RAT; TRANSCRIPTION REGULATION;

ANIMALS; BENZOATES; CELL LINE, TUMOR; DIBENZAZEPINES; EXCITATORY AMINO ACID TRANSPORTER 3; GENE SILENCING; RATS; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; TETRAHYDRONAPHTHALENES; TRETINOIN;

RATTUS; RODENTIA;

EID: 68749087281     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.05.005     Document Type: Article

References (34)

1. Kanai Y., and Hediger M.A. The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers. Arch. 447 (2004) 469-479
2. Tzingounis A.V., and Wadiche J.I. Glutamate transporters: confining runaway excitation by shaping synaptic transmission. Nat. Rev. Neurosci. 8 (2007) 935-947
3. Beart P.M., and O'Shea R.D. Transporters for l-glutamate: an update on their molecular pharmacology and pathological involvement. Br. J. Pharmacol. 150 (2007) 5-17
4. Yang W., and Kilberg M.S. Biosynthesis, intracellular targeting, and degradation of the EAAC1 glutamate/aspartate transporter in C6 glioma cells. J. Biol. Chem. 277 (2002) 38350-38357
5. Ma K., Zheng S., and Zuo Z. The transcription factor regulatory factor X1 increases the expression of neuronal glutamate transporter type 3. J. Biol. Chem. 281 (2006) 21250-21255
6. Bianchi M.G., Gazzola G.C., Tognazzi L., and Bussolati O. C6 glioma cells differentiated by retinoic acid overexpress the glutamate transporter excitatory amino acid carrier 1 (EAAC1). Neuroscience 151 (2008) 1042-1052
7. Zhu W., Kanoh M., Ye P., Laszkiewicz I., Royland J.E., Wiggins R.C., and Konat G. Retinoic acid-regulated expression of proteolipid protein and myelin-associated glycoprotein genes in C6 glioma cells. J. Neurosci. Res. 31 (1992) 745-750
8. Lopez-Barahona M., Minano M., Mira E., Iglesias T., Stunnenberg H.G., Rodriguez-Pena A., Bernal J., and Munoz A. Retinoic acid posttranscriptionally up-regulates proteolipid protein gene expression in C6 glioma cells. J. Biol. Chem. 268 (1993) 25617-25623
9. Balmer J.E., and Blomhoff R. Gene expression regulation by retinoic acid. J. Lipid Res. 43 (2002) 1773-1808
10. Lefebvre P., Martin P.J., Flajollet S., Dedieu S., Billaut X., and Lefebvre B. Transcriptional activities of retinoic acid receptors. Vitam. Horm. 70 (2005) 199-264
11. Ohashi E., Kogai T., Kagechika H., and Brent G.A. Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells. Cancer Res. 69 (2009) 3927-3936
12. Germain P., Chambon P., Eichele G., Evans R.M., Lazar M.A., Leid M., De Lera A.R., Lotan R., Mangelsdorf D.J., and Gronemeyer H. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol. Rev. 58 (2006) 712-725
13. Germain P., Chambon P., Eichele G., Evans R.M., Lazar M.A., Leid M., De Lera A.R., Lotan R., Mangelsdorf D.J., and Gronemeyer H. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol. Rev. 58 (2006) 760-772
14. Mark M., Ghyselinck N.B., and Chambon P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 451-480
15. Dolle P., Ruberte E., Leroy P., Morriss-Kay G., and Chambon P. Retinoic acid receptors and cellular retinoid binding proteins. I. A systematic study of their differential pattern of transcription during mouse organogenesis. Development 110 (1990) 1133-1151
16. Zelent A., Mendelsohn C., Kastner P., Krust A., Garnier J.M., Ruffenach F., Leroy P., and Chambon P. Differentially expressed isoforms of the mouse retinoic acid receptor beta generated by usage of two promoters and alternative splicing. EMBO J. 10 (1991) 71-81
17. Reboul P., George P., Louisot P., and Broquet P. Study of retinoic acid effect upon retinoic acid receptors beta (RAR-beta) in C6 cultured glioma cells. Biochem. Mol. Biol. Int. 36 (1995) 1097-1105
18. Kagechika H., Kawachi E., Hashimoto Y., Himi T., and Shudo K. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. J. Med. Chem. 31 (1988) 2182-2192
19. Umemiya H., Fukasawa H., Ebisawa M., Eyrolles L., Kawachi E., Eisenmann G., Gronemeyer H., Hashimoto Y., Shudo K., and Kagechika H. Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers. J. Med. Chem. 40 (1997) 4222-4234
20. Ebisawa M., Umemiya H., Ohta K., Fukasawa H., Kawachi E., Christoffel G., Gronemeyer H., Tsuji M., Hashimoto Y., Shudo K., and Kagechika H. Retinoid X receptor-antagonistic diazepinylbenzoic acids. Chem. Pharm. Bull. (Tokyo) 47 (1999) 1778-1786
21. Rozen S., and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132 (2000) 365-386
22. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25 (2000) 169-193
23. Farinha C.M., Mendes F., Roxo-Rosa M., Penque D., and Amaral M.D. A comparison of 14 antibodies for the biochemical detection of the cystic fibrosis transmembrane conductance regulator protein. Mol. Cell. Probes 18 (2004) 235-242
24. Nervi C., Vollberg T.M., Grippo J.F., Lucas D.A., George M.D., Sherman M.I., Shudo K., and Jetten A.M. Expression of nuclear retinoic acid receptors in wild-type and mutant embryonal carcinoma PCC4.aza1R cells. Cell. Growth Differ. 1 (1990) 535-542
25. Lansink M., and Kooistra T. Stimulation of tissue-type plasminogen activator expression by retinoic acid in human endothelial cells requires retinoic acid receptor beta 2 induction. Blood 88 (1996) 531-541
26. Ma Q. Induction and superinduction of 2,3,7,8-tetrachlorodibenzo-rho-dioxin-inducible poly(ADP-ribose) polymerase: role of the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator transcription activation domains and a labile transcription repressor. Arch. Biochem. Biophys. 404 (2002) 309-316
27. Hershko D.D., Robb B.W., Wray C.J., Luo G.J., and Hasselgren P.O. Superinduction of IL-6 by cycloheximide is associated with mRNA stabilization and sustained activation of p38 map kinase and NF-kappaB in cultured caco-2 cells. J. Cell. Biochem. 91 (2004) 951-961
28. Joiakim A., Mathieu P.A., Elliott A.A., and Reiners Jr. J.J. Superinduction of CYP1A1 in MCF10A cultures by cycloheximide, anisomycin, and puromycin: a process independent of effects on protein translation and unrelated to suppression of aryl hydrocarbon receptor proteolysis by the proteasome. Mol. Pharmacol. 66 (2004) 936-947
29. Zajac-Kaye M., Ben-Baruch N., Kastanos E., Kaye F.J., and Allegra C. Induction of Myc-intron-binding polypeptides MIBP1 and RFX1 during retinoic acid-mediated differentiation of haemopoietic cells. Biochem. J. 345 Pt. 3 (2000) 535-541
30. Westin S., Kurokawa R., Nolte R.T., Wisely G.B., McInerney E.M., Rose D.W., Milburn M.V., Rosenfeld M.G., and Glass C.K. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 395 (1998) 199-202
31. Lotan R., Dawson M.I., Zou C.C., Jong L., Lotan D., and Zou C.P. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res. 55 (1995) 232-236
32. Idres N., Marill J., and Chabot G.G. Regulation of CYP26A1 expression by selective RAR and RXR agonists in human NB4 promyelocytic leukemia cells. Biochem. Pharmacol. 69 (2005) 1595-1601
33. Lopez-Barahona M., Iglesias T., Garcia-Higuera I., Mayor Jr. F., Zaballos A., Bernal J., and Munoz A. Post-transcriptional induction of beta 1-adrenergic receptor by retinoic acid, but not triiodothyronine, in C6 glioma cells expressing thyroid hormone receptors. Eur. J. Endocrinol. 135 (1996) 709-715
34. Zhang X., Ren Z., Zuo J., Su C., Wang R., Chang Y., and Fang F. The effect of all-trans retinoic acid on gap junctional intercellular communication and connexin 43 gene expression in glioma cells. Chin. Med. Sci. J. 17 (2002) 22-26